97 related articles for article (PubMed ID: 15276071)
21. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
Priceputu E; Hanna Z; Hu C; Simard MC; Vincent P; Wildum S; Schindler M; Kirchhoff F; Jolicoeur P
J Virol; 2007 May; 81(9):4677-93. PubMed ID: 17314161
[TBL] [Abstract][Full Text] [Related]
22. Chemokine (C-C motif) receptor 5 entry inhibitors: new class of drugs for acquired immune deficiency syndrome.
Jacovina A; New M
Mt Sinai J Med; 2008; 75(3):297-8. PubMed ID: 18704982
[No Abstract] [Full Text] [Related]
23. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
[TBL] [Abstract][Full Text] [Related]
24. Chimpanzee CD4+ T cells are relatively insensitive to HIV-1 envelope-mediated inhibition of CD154 up-regulation.
Rutjens E; Vermeulen J; Verstrepen B; Hofman S; Prins JM; Srivastava I; Heeney JL; Koopman G
Eur J Immunol; 2008 Apr; 38(4):1164-72. PubMed ID: 18383039
[TBL] [Abstract][Full Text] [Related]
25. Suppressor activity among CD4+,CD25++ T cells is discriminated by membrane-bound tumor necrosis factor alpha.
Wang J; van Dongen H; Scherer HU; Huizinga TW; Toes RE
Arthritis Rheum; 2008 Jun; 58(6):1609-18. PubMed ID: 18512781
[TBL] [Abstract][Full Text] [Related]
26. BD Biosciences contributions in CD4 counting and immune status for HIV/AIDS.
Hoffman RA; Maino VC; Recktenwald DJ; Webster HK
Cytometry; 2002 Apr; 50(2):129-32. PubMed ID: 12116356
[TBL] [Abstract][Full Text] [Related]
27. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.
Cochrane A; Imlach S; Leen C; Scott G; Kennedy D; Simmonds P
J Virol; 2004 Sep; 78(18):9862-71. PubMed ID: 15331721
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4(+) T cells.
Poiesi C; De Francesco MA; Baronio M; Manca N
Virus Res; 2008 Mar; 132(1-2):25-32. PubMed ID: 18036696
[TBL] [Abstract][Full Text] [Related]
29. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
[TBL] [Abstract][Full Text] [Related]
30. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
31. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
32. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
[TBL] [Abstract][Full Text] [Related]
33. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
[TBL] [Abstract][Full Text] [Related]
34. Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART.
Furco A; Carmagnat M; Chevret S; Garin YJ; Pavie J; De Castro N; Charron D; Derouin F; Rabian C; Molina JM
AIDS; 2008 Oct; 22(16):2087-96. PubMed ID: 18832872
[TBL] [Abstract][Full Text] [Related]
35. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
36. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
37. Perspectives for the chemotherapy of AIDS.
De Clercq E
Chemioterapia; 1988 Dec; 7(6):357-64. PubMed ID: 2905940
[TBL] [Abstract][Full Text] [Related]
38. Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity.
Vermeire K; Lisco A; Grivel JC; Scarbrough E; Dey K; Duffy N; Margolis L; Bell TW; Schols D
Biochem Pharmacol; 2007 Aug; 74(4):566-78. PubMed ID: 17603023
[TBL] [Abstract][Full Text] [Related]
39. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
Williamson MP; McCormick TG; Nance CL; Shearer WT
J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
